Medtronic PLC DRC (MDTC34)

Medtronic PLC DRC stock price live, this page displays BVMF MDTC34 stock exchange data. View the MDTC34 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Medtronic PLC DRC real time stock price chart below.

What Is the Medtronic PLC DRC Stock Price Today?
The Medtronic PLC DRC stock price today is 255.32.

What Is the Stock Symbol for Medtronic PLC DRC?
The stock symbol for Medtronic PLC DRC is "MDTC34."

What Stock Exchange Does Medtronic PLC DRC Trade On?
Medtronic PLC DRC is listed and trades on the B3 stock exchange.

Is Medtronic PLC DRC a Good Stock to Buy?
Determining whether Medtronic PLC DRC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.

You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MDTC34 quote. (ISIN: BRMDTCBDR004)

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists; and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat other non-exclusive diseases and conditions; and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems, and InPen, a smart insulin pen system. The company was founded in 1949 and is headquartered in Galway, Ireland.